Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 17

1.

Clinical and laboratory features of autoimmune hemolytic anemia associated with immune checkpoint inhibitors.

Leaf RK, Ferreri C, Rangachari D, Mier J, Witteles W, Ansstas G, Anagnostou T, Zubiri L, Piotrowska Z, Oo TH, Iberri D, Yarchoan M, Salama AKS, Johnson DB, Leavitt AD, Rahma OE, Reynolds KL, Leaf DE.

Am J Hematol. 2019 Feb 20. doi: 10.1002/ajh.25448. [Epub ahead of print]

PMID:
30790338
2.

Cost-effectiveness and Budgetary Consequence Analysis of Durvalumab Consolidation Therapy vs No Consolidation Therapy After Chemoradiotherapy in Stage III Non-Small Cell Lung Cancer in the Context of the US Health Care System.

Criss SD, Mooradian MJ, Sheehan DF, Zubiri L, Lumish MA, Gainor JF, Reynolds KL, Kong CY.

JAMA Oncol. 2018 Dec 13. doi: 10.1001/jamaoncol.2018.5449. [Epub ahead of print]

PMID:
30543349
3.

Circulating melanoma exosomes as diagnostic and prognosis biomarkers.

Alegre E, Zubiri L, Perez-Gracia JL, González-Cao M, Soria L, Martín-Algarra S, González A.

Clin Chim Acta. 2016 Feb 15;454:28-32. doi: 10.1016/j.cca.2015.12.031. Epub 2015 Dec 24.

PMID:
26724367
4.

Impact of epidermal growth factor receptor (EGFR) activating mutations and their targeted treatment in the prognosis of stage IV non-small cell lung cancer (NSCLC) patients harboring liver metastasis.

Castañón E, Rolfo C, Viñal D, López I, Fusco JP, Santisteban M, Martin P, Zubiri L, Echeveste JI, Gil-Bazo I.

J Transl Med. 2015 Aug 7;13:257. doi: 10.1186/s12967-015-0622-x.

5.

Circulating biomarkers in malignant melanoma.

Alegre E, Sammamed M, Fernández-Landázuri S, Zubiri L, González Á.

Adv Clin Chem. 2015;69:47-89. doi: 10.1016/bs.acc.2014.12.002. Epub 2015 Feb 7. Review.

PMID:
25934359
6.

Quantitative cell-free circulating BRAFV600E mutation analysis by use of droplet digital PCR in the follow-up of patients with melanoma being treated with BRAF inhibitors.

Sanmamed MF, Fernández-Landázuri S, Rodríguez C, Zárate R, Lozano MD, Zubiri L, Perez-Gracia JL, Martín-Algarra S, González A.

Clin Chem. 2015 Jan;61(1):297-304. doi: 10.1373/clinchem.2014.230235. Epub 2014 Nov 19.

7.

Thymidylate synthase polymorphisms in genomic DNA as clinical outcome predictors in a European population of advanced non-small cell lung cancer patients receiving pemetrexed.

Arévalo E, Castañón E, López I, Salgado J, Collado V, Santisteban M, Rodríguez-Ruiz M, Martín P, Zubiri L, Patiño-García A, Rolfo C, Gil-Bazo I.

J Transl Med. 2014 Apr 14;12:98. doi: 10.1186/1479-5876-12-98.

8.

Relevance of MIA and S100 serum tumor markers to monitor BRAF inhibitor therapy in metastatic melanoma patients.

Sanmamed MF, Fernández-Landázuri S, Rodríguez C, Lozano MD, Echeveste JI, Pérez Gracia JL, Alegre E, Carranza O, Zubiri L, Martín-Algarra S, González A.

Clin Chim Acta. 2014 Feb 15;429:168-74. doi: 10.1016/j.cca.2013.11.034. Epub 2013 Dec 9.

PMID:
24333389
9.

Neurological and cytological response as potential early predictors of time-to-progression and overall survival in patients with leptomeningeal carcinomatosis treated with intrathecal liposomal cytarabine: a retrospective cohort study.

Fusco JP, Castañón E, Carranza OE, Zubiri L, Martín P, Espinós J, Rodríguez J, Santisteban M, Aramendía JM, Gil-Bazo I.

J Neurooncol. 2013 Dec;115(3):429-35. doi: 10.1007/s11060-013-1241-0. Epub 2013 Sep 15.

PMID:
24037499
10.

[Use of cryotherapy in the Rochapea Health Centre].

Ansorena R, Zubiri L, Merino R, Cano J, Urdánoz MJ, Cía A, Jiménez O.

An Sist Sanit Navar. 1998 May-Aug;21(2):217-21. Spanish.

11.

Occupation and larynx and hypopharynx cancer: a job-exposure matrix approach in an international case-control study in France, Italy, Spain and Switzerland.

Berrino F, Richiardi L, Boffetta P, Estève J, Belletti I, Raymond L, Troschel L, Pisani P, Zubiri L, Ascunce N, Gubéran E, Tuyns A, Terracini B, Merletti F; Milan JEM Working Group.

Cancer Causes Control. 2003 Apr;14(3):213-23.

PMID:
12814200
12.

Occupation and larynx and hypopharynx cancer: an international case-control study in France, Italy, Spain, and Switzerland.

Boffetta P, Richiardi L, Berrino F, Estève J, Pisani P, Crosignani P, Raymond L, Zubiri L, Del Moral A, Lehmann W, Donato F, Terracini B, Tuyns A, Merletti F.

Cancer Causes Control. 2003 Apr;14(3):203-12.

PMID:
12814199
13.

Diet and cancers of the larynx and hypopharynx: the IARC multi-center study in southwestern Europe.

Estève J, Riboli E, Péquignot G, Terracini B, Merletti F, Crosignani P, Ascunce N, Zubiri L, Blanchet F, Raymond L, Repetto F, Tuyns AJ.

Cancer Causes Control. 1996 Mar;7(2):240-52.

PMID:
8740737
14.

Cancer of the endolarynx, epilarynx and hypopharynx in south-western Europe: assessment of tumoral origin and risk factors.

Lehmann W, Raymond L, Faggiano F, Sancho-Garnier H, Blanchet F, Del Moral A, Zubiri L, Terracini B, Berrino F, Pequignot G, et al.

Adv Otorhinolaryngol. 1991;46:145-56. No abstract available.

PMID:
1927713
15.

[Fixed cutaneous sporotrichosis localized on the face, with an infrequently seen clinical picture].

Simal E, Navarro M, Coscojuela C, Zubiri L, Rubio MC, Carapeto FJ.

Med Cutan Ibero Lat Am. 1988;16(3):201-3. Spanish.

PMID:
3059087
16.

[Lyell's syndrome. Clinical, histological, enzymatic and ultrastructural study].

Grasa MP, Zubiri L, Marrón J, Abascal M, Domínguez M, Navarro M, Carapeto FJ.

Actas Dermosifiliogr. 1981 May-Jun;72(5-6):225-8. Spanish. No abstract available.

PMID:
7315584
17.

[Chemotherapy of the advanced cancer of the rectum].

Navarro Izquierdo A, Zubiri L, Paracuellos S, Solsona F.

Rev Esp Enferm Apar Dig. 1977 Jan 1;49(1):65-72. Spanish. No abstract available.

PMID:
64994

Supplemental Content

Loading ...
Support Center